Stage-specific proteins ofPlasmodium berghei-infected red blood cells detected by antibodies of immune mouse serum

1988 ◽  
Vol 75 (1) ◽  
pp. 69-72 ◽  
Author(s):  
T. P. M. Schetters ◽  
C. C. Hermsen ◽  
A. A. J. C. Van Zon ◽  
W. M. C. Eling
Keyword(s):  
Red Blood Cells ◽  
Blood Cells ◽  
Mouse Serum ◽  
Immune Mouse ◽  
Specific Proteins ◽  
Immune Mouse Serum

Resistance of Trypanosoma cruzi to Blood Clearance Induced by Acute-Phase Immune Mouse Serum

1992 ◽  
Vol 78 (6) ◽  
pp. 1074
Author(s):  
José M. Alvarez ◽  
Claudio Romero Farias Marinho ◽  
Ayumi Oshima ◽  
Liliane Guimaraes ◽  
Hércules Menezes ◽  
...  
Keyword(s):  
Trypanosoma Cruzi ◽  
Acute Phase ◽  
Mouse Serum ◽  
Blood Clearance ◽  
Immune Mouse ◽  
Immune Mouse Serum

A Hæmagglutinating Property of Mouse Serum for Human Red Blood Cells

Nature ◽  
1963 ◽  
Vol 200 (4907) ◽  
pp. 687-688 ◽  
Author(s):  
I. KIRSHBOM ◽  
G. HOECKER
Keyword(s):  
Red Blood Cells ◽  
Blood Cells ◽  
Mouse Serum ◽  
Human Red Blood Cells

Microbicidal activity of hydrolyzed toxoplasma immune mouse serum (HS-LKs) in heterologous cell cultures.

1982 ◽  
Vol 10 (3/4) ◽  
pp. 183-195 ◽  
Author(s):  
HARUHISA SAKURAI ◽  
MOTOYOSHI SATO ◽  
TSUNEO HIROSE ◽  
YOSHITAKA OMATA ◽  
ATSUSHI SAITO ◽  
...  
Keyword(s):  
Cell Cultures ◽  
Mouse Serum ◽  
Immune Mouse ◽  
Microbicidal Activity ◽  
Heterologous Cell ◽  
Immune Mouse Serum

scholarly journals Candidacidal activity of mouse macrophages in vitro

1980 ◽  
Vol 29 (2) ◽  
pp. 477-482 ◽  
Author(s):  
P K Maiti ◽  
R Kumar ◽  
L N Mohapatra
Keyword(s):  
Peritoneal Macrophages ◽  
Mouse Serum ◽  
Activated Macrophages ◽  
Immune Mouse ◽  
Mouse Macrophages ◽  
In Vitro Exposure ◽  
Candida Infections ◽  
Mouse Peritoneal Macrophages ◽  
Immune Mouse Serum

Mouse peritoneal macrophages were infected in vitro with Candida albicans, and the phagocytic and candidacidal activities were estimated by microscopic examination of Giemsa-stained cells. Activated macrophages obtained from either BCG-vaccinated animals or by in vitro exposure of normal macrophages to phytohemagglutinin-induced lymphokines exhibited higher phagocytic and candidacidal activities than did normal macrophages. However, activated macrophages obtained by in vitro exposure of macrophages to candida-induced lymphokines exhibited the highest phagocytic and candidacidal activities. The incorporation of immune mouse serum into the culture medium also enhanced the phagocytic and candidacidal activities of the normal macrophages but failed to improve the function of the activated macrophages. These results suggest that both activated macrophages and antibodies may be required for controlling candida infections in mice.

scholarly journals THE PASSIVE TRANSFER OF ACQUIRED RESISTANCE TO LISTERIA MONOCYTOGENES

1964 ◽  
Vol 120 (1) ◽  
pp. 93-103 ◽  
Author(s):  
K. Miki ◽  
G. B. Mackaness
Keyword(s):  
Listeria Monocytogenes ◽  
Acquired Resistance ◽  
Survival Rates ◽  
Peritoneal Macrophages ◽  
Passive Transfer ◽  
Mouse Serum ◽  
Immune Mouse ◽  
Passive Protection ◽  
Mouse Macrophages ◽  
Immune Mouse Serum

Five methods have been used in an effort to reveal an antibody that could account for the features of acquired resistance to Listeria monocytogenes: (a) a comparison of the growth rates of Listeria in the spleens of mice infused repeatedly with normal or immune mouse serum; (b) measurement of peritoneal clearance of Listeria in the presence of normal or immune mouse serum; (c) the survival rate of Listeria in monolayers of mouse macrophages infected in the presence of normal or immune mouse serum; (d) the effect of injecting urea extracts of spleens and peritoneal macrophages of normal or immune mice on the survival and growth of Listeria in recipient animals; (e) a comparison of survival rates in lethally infected mice following the passive transfer of cells and serum from normal or immune donors. The only evidence of passive protection was obtained when intact living cells from immune donors were used for transfer under conditions which permitted them to interact with the parasite population.

scholarly journals Virus-replicating T cells in the immune response of mice. I. Virus plaque assay of the lymphocytes reactive to sheep erythrocytes.

1977 ◽  
Vol 145 (2) ◽  
pp. 390-404 ◽  
Author(s):  
N Minato ◽  
Y Katsura
Keyword(s):  
Immune Response ◽  
T Cells ◽  
Red Blood Cells ◽  
Blood Cells ◽  
Cultured Cells ◽  
Plaque Assay ◽  
Delayed Type Hypersensitivity ◽  
Mouse Serum ◽  
Spleen Cells ◽  
Helper Activity

Virus plaque-forming cell assay with vesicular stomatitis virus (VSV), which had been originally introduced by Bloom and his colleagues as a tool for the enumeration of activated lymphocytes, was first applied to the immune response of mice to a widely used antigen, i.e. sheep red blood cells (SRBC). When spleen cells taken from mice previously primed with SRBC were cultured in the presence of the antigen, lymphocytes capable of replicating VSV (antigen-induced virus plaque-forming cells, Ag-V-PFC) were generated in the culture. They seemed to appear as early as 1 day of culture, and the peak was attained by the 2nd day. Most of Ag-V-PFC belonged to T-cell population, since 80-90% of Ag-V-PFC was killed by the treatment of cultured cells with anti-thymocyte serum plus complement. In vitro generation of Ag-V-PFC seemed to be highly cross-reactive (about 40%) with a related antigen (horse red blood cells). Ag-V-PFC detected in the present experiment may not represent helper T cells, effector T cells, or their precursors because of the following: (a) The generation of Ag-V-PFC was completely suppressed by the addition of anti-SRBC mouse serum in the culture, though the helper activity was apparently augmented by the same treatment. (b) Development of Ag-V-PFC was almost completely suppressed by the pretreatment of mice with cyclophosphamide 2 days before immunization, by which delayed-type hypersensitivity (DTH) was markedly augmented. (c) After the immunization of mice, Ag-V-PFC began to develop just when the level of DTH declined, at which point helper activity of the spleen cells also diminished. A possible role of Ag-V-PFC in the immune response was discussed.

Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects--incidence, species specificity, and effects on a two-site assay for creatine kinase-MB isoenzyme.

1986 ◽  
Vol 32 (3) ◽  
pp. 476-481 ◽  
Author(s):  
R J Thompson ◽  
A P Jackson ◽  
N Langlois
Keyword(s):  
Blood Donors ◽  
Solid Phase ◽  
Normal Subjects ◽  
Rabbit Serum ◽  
Mouse Serum ◽  
Serum Samples ◽  
Immune Mouse ◽  
Creatine Kinase Mb ◽  
Circulating Antibodies ◽  
Immune Mouse Serum

Abstract With a two-site CK-MB assay, we screened serum samples from 1008 blood donors for the presence of antibodies to mouse monoclonal immunoglobulin. These antibodies were capable of cross-linking the labeled antibody with the solid-phase antibody in the two-site assay, thus generating a falsely high apparent CK-MB concentration. In 92 (9.12%) of the blood donors tested, apparent CK-MB concentrations of 10-1000 micrograms/L decreased to less than 3 micrograms/L when re-assayed with non-immune mouse serum (10 mL/L) included in the assay reagent. We tested the ability of non-immune sera from other animal species to lower the concentration of apparent CK-MB in 58 of the 92 samples. Bovine and ovine serum were almost as effective as mouse serum; feline, canine, and rabbit serum were less effective. Of the samples tested, 12% (1.1% of the original population screened) showed apparent CK-MB values that either were not depressed by bovine serum or were only partly depressed. We discuss the possible etiology of these antibodies in normal subjects and recommend that all mouse monoclonal two-site assays should contain non-immune mouse serum (or a suitable "irrelevant" mouse monoclonal antibody) to prevent false-positive results.

Sign in / Sign up

Export Citation Format

Share Document